Open NebulaExplore
← Back to Nebula
October 20, 2026StocksTechnology·Bullish·regulatory

FDA approves GSK's first-of-its-kind chronic hepatitis B treatment Hibsago (bepirovirsen)

The FDA approved GSK's Hibsago (bepirovirsen), a first-of-its-kind treatment for chronic hepatitis B in adults without cirrhosis, offering patients a chance to stop long-term treatment.

Detected & updated continuously · Source: Nebula

Story subjects

Food and Drug AdministrationHibsago (Bepirovirsen)

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula